Lymph-directed nitric oxide increases immune cell access to lymph-borne nanoscale solutes.
Ontology highlight
ABSTRACT: Lymph nodes (LNs) are immune organs housing high concentrations of lymphocytes, making them critical targets for therapeutic immunomodulation in a wide variety of diseases. While there is great interest in targeted drug delivery to LNs, many nanoscale drug delivery carriers have limited access to parenchymal resident immune cells compared to small molecules, limiting their efficacy. Nitric oxide (NO) is a potent regulator of vascular and lymphatic transport and a promising candidate for modulating nanocarrier access to LNs, but its lymphatic accumulation is limited by its low molecular weight and high reactivity. In this work, we employ S-nitrosated nanoparticles (SNO-NP), a lymphatic-targeted delivery system for controlled NO release, to investigate the effect of NO application on molecul
SUBMITTER: Sestito LF
PROVIDER: S-EPMC7968442 | biostudies-literature | 2021 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA